Pegaspargase Induced Hypertriglyceridemia Resulting in Severe Fatal Pancreatitis
Joint Authors
Vyas, Neil
Ching Companioni, Rafael
Tiba, Melik
Alkhawam, Hassan
Walfish, Aaron
Source
Case Reports in Gastrointestinal Medicine
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-11-29
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
Pegaspargase is used to treat acute lymphocytic leukemia (ALL).
Pegaspargase definitely has its benefits in treating ALL; however we cannot lose sight of one of its very rare but potentially deadly complications, acute pancreatitis.
Clinicians should monitor triglycerides while the patient is on treatment with Pegaspargase and suspect acute pancreatitis if the patient develops abdominal pain.
If pancreatitis occurs, therapy should be stopped immediately and not reinstituted.
For patients with hypertriglyceridemia without pancreatitis, discontinuation of therapy should be considered.
American Psychological Association (APA)
Vyas, Neil& Ching Companioni, Rafael& Tiba, Melik& Alkhawam, Hassan& Walfish, Aaron. 2015. Pegaspargase Induced Hypertriglyceridemia Resulting in Severe Fatal Pancreatitis. Case Reports in Gastrointestinal Medicine،Vol. 2015, no. 2015, pp.1-2.
https://search.emarefa.net/detail/BIM-1058565
Modern Language Association (MLA)
Vyas, Neil…[et al.]. Pegaspargase Induced Hypertriglyceridemia Resulting in Severe Fatal Pancreatitis. Case Reports in Gastrointestinal Medicine No. 2015 (2015), pp.1-2.
https://search.emarefa.net/detail/BIM-1058565
American Medical Association (AMA)
Vyas, Neil& Ching Companioni, Rafael& Tiba, Melik& Alkhawam, Hassan& Walfish, Aaron. Pegaspargase Induced Hypertriglyceridemia Resulting in Severe Fatal Pancreatitis. Case Reports in Gastrointestinal Medicine. 2015. Vol. 2015, no. 2015, pp.1-2.
https://search.emarefa.net/detail/BIM-1058565
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1058565
